2-methylmorpholine pyrido-, pyrazoand pyrimido-pyrimidine derivatives as mTOR inhibitors

Details for Australian Patent Application No. 2007287430 (hide)

Owner KuDOS Pharmaceuticals Limited

Inventors Leroux, Frederic Georges Marie; Martin, Niall Morrisson Barr; Smith, Graeme Cameron Murray; Duggan, Heather Mary Ellen; Menear, Keith Allan; Malagu, Karine

Agent Davies Collison Cave

Pub. Number AU-B-2007287430

PCT Pub. Number WO2008/023161

Priority 60/823,311 23.08.06 US; 60/938,776 18.05.07 US

Filing date 21 August 2007

Wipo publication date 28 February 2008

Acceptance publication date 21 July 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 March 2009 PCT application entered the National Phase

  PCT publication WO2008/023161 Priority application(s): WO2008/023161

21 July 2011 Application Accepted

  Published as AU-B-2007287430

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007287443-Reduction of noise in electrical field measurements

2007287428-Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders